• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于临床病理及超声影像特征的列线图预测cN0期单侧甲状腺微小乳头状癌颈部淋巴结转移

A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma.

作者信息

Zhang Lina, Ling Yuwei, Zhao Ye, Li Kaifu, Zhao Jing, Kang Hua

机构信息

Department of General Surgery, Center for Thyroid and Breast Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

Department of Colorectal Surgery, PLA Rocket Force Characteristics Medical Center, Beijing, China.

出版信息

Front Surg. 2021 Dec 3;8:742328. doi: 10.3389/fsurg.2021.742328. eCollection 2021.

DOI:10.3389/fsurg.2021.742328
PMID:34926565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8677692/
Abstract

The aim of this study was to establish a practical nomogram for preoperatively predicting the possibility of cervical lymph node metastasis (CLNM) based on clinicopathological and ultrasound (US) imaging characteristics in patients with clinically node-negative (cN0) unilateral papillary thyroid microcarcinoma (PTMC) in order to determine a personal surgical volume and therapeutic strategy. A total of 269 consecutive patients diagnosed with cN0 unilateral PTMC by postoperative pathological examination from January 2018 to December 2020 were retrospectively analyzed. All the patients underwent lobectomy or thyroidectomy with routine prophylactic central lymph node dissection (CLND) and were divided into a CLNM group and a non-CLNM group. Using logistic regression, the least absolute shrinkage and selection operator (LASSO) regression analysis was applied to determine the risk factors for CLNM in patients with unilateral cN0 PTMC. A nomogram including risk-factor screening using LASSO regression for predicting the CLNM in patients with cN0 unilateral PTMC was further developed and validated. Risk factors identified by LASSO regression, including age, sex, tumor size, presence of extrathyroidal extension (ETE), tumor diameter/lobe thickness (D/T), tumor location, and coexistent benign lesions, were potential predictors for CLNM in patients with cN0 unilateral PTMC. Meanwhile, age (odds ratio [OR] = 0.261, 95% CI.104-0.605; = 0.003), sex (men: OR = 3.866; 95% CI 1.758-8.880; < 0.001), ETE (OR = 3.821; 95% CI 1.168-13.861; = 0.032), D/T (OR = 72.411; 95% CI 5.483-1212.497; < 0.001), and coexistent benign lesions (OR = 3.112 95% CI 1.407-7.303; = 0.007) were shown to be significantly related to CLNM by multivariant logistic regression. A nomogram for predicting CLNM in patients with cN0 unilateral PTMC was established based on the risk factors identified by the LASSO regression analysis. The receiver operating characteristic (ROC) curve for predicting CLNM by nomogram showed that the area under the curve (AUC) was 0.777 and exhibited an excellent consistency. A nomogram based on clinical and US imaging characteristics for predicting the probability of CLNM in patients with cN0 unilateral PTMC was developed, which showed a favorable predictive value and consistency. Further prospective research to observe the oncological outcomes is necessary to determine whether the nomogram could potentially guide a personalized surgical volume and surgical approach.

摘要

本研究旨在基于临床病理和超声(US)影像特征,为临床淋巴结阴性(cN0)的单侧甲状腺微小乳头状癌(PTMC)患者建立一个术前预测颈部淋巴结转移(CLNM)可能性的实用列线图,以确定个体化的手术范围和治疗策略。回顾性分析了2018年1月至2020年12月期间经术后病理检查确诊为cN0单侧PTMC的269例连续患者。所有患者均接受了叶切除术或甲状腺切除术及常规预防性中央淋巴结清扫(CLND),并分为CLNM组和非CLNM组。采用逻辑回归分析,应用最小绝对收缩和选择算子(LASSO)回归分析确定单侧cN0 PTMC患者CLNM的危险因素。进一步开发并验证了一个包括使用LASSO回归进行危险因素筛选以预测cN0单侧PTMC患者CLNM的列线图。LASSO回归确定的危险因素,包括年龄、性别、肿瘤大小、甲状腺外侵犯(ETE)的存在、肿瘤直径/叶厚度(D/T)、肿瘤位置和并存的良性病变,是cN0单侧PTMC患者CLNM的潜在预测因素。同时,多变量逻辑回归显示,年龄(比值比[OR]=0.261,95%可信区间0.104 - 0.605;P = 0.003)、性别(男性:OR = 3.866;95%可信区间1.758 - 8.880;P < 0.001)、ETE(OR = 3.821;95%可信区间1.168 - 13.861;P = 0.032)、D/T(OR = 72.411;95%可信区间5.483 - 1212.497;P < 0.001)和并存的良性病变(OR = 3.112,95%可信区间1.407 - 7.303;P = 0.007)与CLNM显著相关。基于LASSO回归分析确定的危险因素,建立了cN0单侧PTMC患者CLNM的预测列线图。通过列线图预测CLNM的受试者工作特征(ROC)曲线显示,曲线下面积(AUC)为0.777,具有良好的一致性。开发了基于临床和US影像特征预测cN0单侧PTMC患者CLNM概率的列线图,其显示出良好的预测价值和一致性。有必要进行进一步的前瞻性研究以观察肿瘤学结局,以确定该列线图是否有可能指导个体化的手术范围和手术方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/afbfdc793703/fsurg-08-742328-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/36f157bb837b/fsurg-08-742328-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/89a622b9e710/fsurg-08-742328-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/e00cf07ffde5/fsurg-08-742328-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/afbfdc793703/fsurg-08-742328-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/36f157bb837b/fsurg-08-742328-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/89a622b9e710/fsurg-08-742328-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/e00cf07ffde5/fsurg-08-742328-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681a/8677692/afbfdc793703/fsurg-08-742328-g0004.jpg

相似文献

1
A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma.基于临床病理及超声影像特征的列线图预测cN0期单侧甲状腺微小乳头状癌颈部淋巴结转移
Front Surg. 2021 Dec 3;8:742328. doi: 10.3389/fsurg.2021.742328. eCollection 2021.
2
Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.建立预测甲状腺微小乳头状癌中央区淋巴结转移的列线图。
BMC Cancer. 2024 Feb 20;24(1):235. doi: 10.1186/s12885-024-12004-3.
3
The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.预测伴有桥本甲状腺炎的 cN0 期甲状腺微小乳头状癌中央区淋巴结转移的模型。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1330896. doi: 10.3389/fendo.2024.1330896. eCollection 2024.
4
Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.临床淋巴结阴性甲状腺微小乳头状癌患者中央淋巴结转移危险因素的识别及预防性中央区颈淋巴结清扫对分期迁移和风险分层影响的评估
Bull Cancer. 2017 Jun;104(6):516-523. doi: 10.1016/j.bulcan.2017.03.005. Epub 2017 May 2.
5
A model based on ultrasound and clinical factors to predict central lymph node metastasis in cN0 papillary thyroid microcarcinoma.一种基于超声和临床因素预测cN0期甲状腺微小乳头状癌中央淋巴结转移的模型。
Heliyon. 2024 Jun 28;10(13):e33891. doi: 10.1016/j.heliyon.2024.e33891. eCollection 2024 Jul 15.
6
Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌颈淋巴结转移风险术前预测列线图
Front Endocrinol (Lausanne). 2021 Mar 31;12:613974. doi: 10.3389/fendo.2021.613974. eCollection 2021.
7
Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.cN0 期甲状腺微小乳头状癌高容量中央区淋巴结转移的临床及超声危险因素:一项回顾性研究与Meta分析
Clin Endocrinol (Oxf). 2023 Apr;98(4):609-621. doi: 10.1111/cen.14834. Epub 2022 Nov 3.
8
A nomogram based on ultrasound radiomics for predicting the invasiveness of cN0 single papillary thyroid microcarcinoma.一种基于超声影像组学的列线图,用于预测cN0期单发性甲状腺微小乳头状癌的侵袭性。
Gland Surg. 2023 Dec 26;12(12):1735-1745. doi: 10.21037/gs-23-473. Epub 2023 Dec 22.
9
Web-Based Ultrasonic Nomogram Predicts Preoperative Central Lymph Node Metastasis of cN0 Papillary Thyroid Microcarcinoma.基于网络的超声列线图预测 cN0 期甲状腺微小乳头状癌的术前中央区淋巴结转移。
Front Endocrinol (Lausanne). 2021 Sep 7;12:734900. doi: 10.3389/fendo.2021.734900. eCollection 2021.
10
A multivariable model of BRAF and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma.用于预测cN0期甲状腺微小乳头状癌中央淋巴结转移风险的BRAF与超声特征多变量模型
Cancer Manag Res. 2019 Jul 30;11:7211-7217. doi: 10.2147/CMAR.S199921. eCollection 2019.

引用本文的文献

1
Risk nomogram for papillary thyroid microcarcinoma with central lymph node metastasis and postoperative thyroid function follow-up.甲状腺微小乳头状癌中央区淋巴结转移风险列线图及其术后甲状腺功能随访
Front Endocrinol (Lausanne). 2024 Oct 28;15:1395900. doi: 10.3389/fendo.2024.1395900. eCollection 2024.
2
The role of intraoperative central lymph node biopsy in the treatment of clinically low-risk PTMC.术中中央区淋巴结活检在临床低危 PTMC 治疗中的作用。
Endocrine. 2024 Nov;86(2):753-760. doi: 10.1007/s12020-024-03851-y. Epub 2024 Jun 27.
3
The diagnostic value of a nomogram based on multimodal ultrasonography for thyroid-nodule differentiation: A multicenter study.

本文引用的文献

1
Carbon nanoparticle-guided intraoperative lymph node biopsy predicts the status of lymph nodes posterior to right recurrent laryngeal nerve in cN0 papillary thyroid carcinoma.碳纳米颗粒引导的术中淋巴结活检可预测cN0期乳头状甲状腺癌患者右侧喉返神经后方淋巴结的状态。
Gland Surg. 2021 May;10(5):1554-1563. doi: 10.21037/gs-20-920.
2
Can preoperative ultrasound predict extrathyroidal extension of differentiated thyroid cancer?术前超声能否预测分化型甲状腺癌的甲状腺外侵犯?
Eur J Endocrinol. 2021 May 21;185(1):13-22. doi: 10.1530/EJE-21-0091.
3
Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
基于多模态超声的列线图对甲状腺结节鉴别诊断的价值:一项多中心研究
Front Oncol. 2022 Aug 18;12:970758. doi: 10.3389/fonc.2022.970758. eCollection 2022.
4
Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.分析 cT1N0 期甲状腺乳头状癌中央区淋巴结转移的相关危险因素。
Front Endocrinol (Lausanne). 2022 Jun 3;13:880911. doi: 10.3389/fendo.2022.880911. eCollection 2022.
5
A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.一种用于预测甲状腺微小乳头状癌患者中央区淋巴结转移风险的新工具:一项回顾性队列研究。
BMC Cancer. 2022 Jun 2;22(1):606. doi: 10.1186/s12885-022-09655-5.
甲状腺微小乳头状癌颈淋巴结转移风险术前预测列线图
Front Endocrinol (Lausanne). 2021 Mar 31;12:613974. doi: 10.3389/fendo.2021.613974. eCollection 2021.
4
A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.回顾性研究淋巴结转移数量对甲状腺乳头状癌患者的危险因素和预后的影响。
Clin Exp Med. 2021 May;21(2):277-286. doi: 10.1007/s10238-020-00675-8. Epub 2021 Jan 1.
5
Risk factors of papillary thyroid microcarcinoma that predispose patients to local recurrence.导致甲状腺微小乳头状癌局部复发的风险因素。
PLoS One. 2020 Dec 31;15(12):e0244930. doi: 10.1371/journal.pone.0244930. eCollection 2020.
6
Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.低危型甲状腺乳头状癌的早期诊断结果往往是过度治疗而非更好的生存。
Front Endocrinol (Lausanne). 2020 Oct 6;11:571421. doi: 10.3389/fendo.2020.571421. eCollection 2020.
7
Role of intraoperative neuromonitoring of recurrent laryngeal nerve in thyroid and parathyroid surgery.喉返神经术中神经监测在甲状腺和甲状旁腺手术中的作用
J Int Med Res. 2020 Sep;48(9):300060520952646. doi: 10.1177/0300060520952646.
8
Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a single center retrospective study.临床病理因素及术前超声特征预测甲状腺微小乳头状癌中央区淋巴结转移:单中心回顾性研究。
Braz J Otorhinolaryngol. 2022 Jan-Feb;88(1):36-45. doi: 10.1016/j.bjorl.2020.05.004. Epub 2020 Jun 4.
9
Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.根据中央淋巴结转移风险评分模型和复发预测因素管理 cN0 甲状腺微小乳头状癌患者。
J Endocrinol Invest. 2020 Dec;43(12):1807-1817. doi: 10.1007/s40618-020-01326-1. Epub 2020 Jun 18.
10
Preoperative assessment of extrathyroidal extension of papillary thyroid carcinomas by ultrasound and magnetic resonance imaging: a comparative study.超声与磁共振成像对甲状腺外侵犯的甲状腺乳头状癌术前评估的对比研究。
Radiol Med. 2020 Sep;125(9):870-876. doi: 10.1007/s11547-020-01184-0. Epub 2020 Apr 5.